Categories: News

Point-of-Care, Biosensors and Mobile Diagnostics Conference Europe 2022: Overview of POC Testing Landscape, from Novel Technologies to Regulatory Approval – Rotterdam, Netherlands – June 21-22, 2022

DUBLIN, May 26, 2022 /PRNewswire/ — The “Point-of-Care, Biosensors and Mobile Diagnostics Europe 2022” conference has been added to ResearchAndMarkets.com’s offering.

This conference will provide an overview of the point-of-care (POC) testing landscape, from novel technologies to regulatory approval.

The aim of this meeting is to bring together life science researchers that work at the interface between biology and chemistry and technology development to discuss problems, highlight solutions and facilitating collaborations. Emphasis will be placed on mobile diagnostics platforms and convergence with microfluidics-based and lab-on-a-chip approaches.

Point-of-Care, Biosensors & Mobile Diagnostics Europe 2022 to be held on-site as a standard physical conference at the Hilton Rotterdam brings together the key opinion leaders from both academia and industry, this annual conference will discuss the expanding Point-of-Care Diagnostics and Biosensors fields and provide the most up-to-date presentations from leaders in these fields and offer networking and engagement opportunities with delegates from around the world.

Agenda:

  • Biosensors
  • Impact of Microfluidics/Lab-on-a-Chip Technologies for Point-of-Care (POC) Diagnostics Applications
  • Low Cost POC Diagnostics Platforms for Deployment Worldwide
  • Next Generation Technologies for Pathogen Detection: Pandemics and Biosurveillance
  • Rapid Biodetection of Pathogens and Threat Identification: Pandemics and Biosurveillance
  • SARS-CoV-2 Rapid Diagnostics and Global Health
  • Wearable and Implantable Devices and Mobile Diagnostics Platforms/Devices

Speakers

Keynote Speakers

Holger Schmidt
Narinder Kapany Professor of Electrical Engineering, University of California-Santa Cruz

Marloes Peeters
Deputy Director of Chemical Engineering, Newcastle University

Arben Merkoci
ICREA Professor and Director of the Nanobioelectronics & Biosensors Group, Institut Catala de Nanociencia i Nanotecnologia (ICN2), Barcelona Institute of Science and Technology (BIST)

Karolien De Wael
Full Professor, Antwerp University

For more information about this conference visit https://www.researchandmarkets.com/r/aygvcm

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

 

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

 

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 

View original content:https://www.prnewswire.com/news-releases/point-of-care-biosensors-and-mobile-diagnostics-conference-europe-2022-overview-of-poc-testing-landscape-from-novel-technologies-to-regulatory-approval—rotterdam-netherlands—june-21-22-2022-301555721.html

SOURCE Research and Markets

Staff

Recent Posts

Bemax Announces Financial Results for Fiscal Fourth Quarter Ended May 31, 2024

- Revenue increase of over 600%Dallas, Georgia--(Newsfile Corp. - July 2, 2024) - Bemax Inc.…

1 hour ago

1933 Industries Reports Profit in Q3 2024 Financials

VANCOUVER, BC / ACCESSWIRE / July 2, 2024 / 1933 Industries Inc. (the "Company" or…

1 hour ago

Myriad Genetics Earns 2024 Great Place To Work® Certification™

SALT LAKE CITY, July 02, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a…

1 hour ago

Scilex Holding Company to Ring Nasdaq Closing Bell on Friday, July 5th at 4:00PM ET at the Nasdaq MarketSite in Times Square, New York

The ceremony will be held in celebration of Scilex’s launch of GLOPERBA®, an innovative non-opioid…

1 hour ago

Positive Phase 1 Clinical Data of MTX110 in DMG Brain Cancer Demonstrating Increased Survival Presented at ISPNO 2024

July 2, 2024 Biodexa Pharmaceuticals PLC Positive Phase 1 Clinical Data of MTX110 in DMG…

1 hour ago